waterstreetlogo (1)

The Gulf Central Committee for Drug Registration (GCC-DR) was approved on the 15th of May in 1999 by the Executive Office for Health Ministers in Riyadh, Saudi Arabia. The GCC-DR committee consists of two state nominated representatives from Bahrain, Kuwait, Oman, Qatar, Saudi Arabia and the United Arab Emirates (UAE).